Bonus BioGroup Ltd. Stock TEL AVIV STOCK EXCHANGE
Equities
BONS
IL0004850116
Biotechnology & Medical Research
Sales 2022 | - | Sales 2023 | - | Capitalization | 195M 725M |
---|---|---|---|---|---|
Net income 2022 | -38M -141M | Net income 2023 | -28M -104M | EV / Sales 2022 | - |
Net cash position 2022 | 41.67M 155M | Net cash position 2023 | 14.82M 55.08M | EV / Sales 2023 | - |
P/E ratio 2022 |
-5.79
x | P/E ratio 2023 |
-6.84
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 54.94% |
Managers | Title | Age | Since |
---|---|---|---|
Shai Meretzki
FOU | Founder | 55 | 12-04-28 |
Yoni Livne
DFI | Director of Finance/CFO | 49 | 14-05-31 |
Atara Novak
CTO | Chief Tech/Sci/R&D Officer | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Shai Meretzki
FOU | Founder | 55 | 12-04-28 |
Benjamin Shafir
BRD | Director/Board Member | 74 | 20-09-28 |
Gil Shapira
BRD | Director/Board Member | 65 | 12-04-28 |
1st Jan change | Capi. | |
---|---|---|
-15.05% | 1.1B | |
-22.03% | 126M | |
+3.72% | 75.91M | |
+5.15% | 60.02M |